Management of Elevated Ferritin with High Iron Saturation

Initial Assessment

The combination of markedly elevated ferritin (>1000 ng/mL) and high transferrin saturation (>45%) is highly suggestive of iron overload, particularly hemochromatosis, in patients with elevated ferritin and transferrin saturation, according to the American Association for the Study of Liver Diseases 1, 2
This pattern distinguishes true iron overload from other causes of isolated hyperferritinemia such as inflammation, malignancy, or liver disease, with a high degree of specificity, as stated by the American Association for the Study of Liver Diseases 2
When ferritin exceeds 1000 μg/L with elevated transferrin saturation, there is significant risk of organ damage, particularly liver fibrosis, as reported by the American Association for the Study of Liver Diseases 1

HFE gene testing for C282Y and H63D mutations should be performed as the next step in patients with elevated ferritin and transferrin saturation, as recommended by the European Association for the Study of the Liver 1, 3
C282Y homozygosity is the most common genotype in hemochromatosis, accounting for the majority of cases, according to the European Association for the Study of the Liver 3
If ferritin >1000 μg/L with elevated liver enzymes, liver biopsy should be considered to assess for fibrosis/cirrhosis, as suggested by the American Association for the Study of Liver Diseases 1, 3
A serum ferritin >1000 μg/L with elevated aminotransferases and platelet count <200 predicts cirrhosis in 80% of C282Y homozygotes, with a high degree of accuracy, as reported by the American Association for the Study of Liver Diseases 1

Therapeutic phlebotomy is the cornerstone of treatment for confirmed hemochromatosis, as recommended by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver 1, 3
Target ferritin level should be <500 μg/L to avoid toxicity of iron overload, as stated by the American Society of Hematology 4
For patients who develop anemia during phlebotomies despite elevated ferritin, extension of the phlebotomy interval is recommended, as suggested by the American Society of Hematology 4

First-degree relatives should be screened with serum ferritin, transferrin saturation, and HFE genetic testing if the patient is confirmed to have hemochromatosis, as recommended by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver 1, 3
This is particularly important for siblings who have a 25% chance of being affected if the proband has hereditary hemochromatosis, with a significant risk of developing the disease, as reported by the European Association for the Study of the Liver 3

Regular monitoring of ferritin levels during treatment is essential, as recommended by the American Society of Hematology 4
Once target ferritin is reached, maintenance phlebotomies are typically needed 3-4 times per year, as suggested by the American Association for the Study of Liver Diseases 1
Ongoing surveillance for complications (diabetes, arthropathy, cardiac issues) is recommended, as stated by the American Association for the Study of Liver Diseases 1